Home

Akebia Therapeutics, Inc. - Common Stock (AKBA)

1.8000
0.00 (0.00%)

Akebia Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with kidney disease

The company is primarily engaged in addressing unmet medical needs in anemia caused by chronic kidney disease, aiming to enhance patient outcomes through its proprietary treatments and drug candidates. Akebia's research and development efforts are centered around creating therapies that improve the management of renal diseases by promoting better health and quality of life for patients suffering from kidney-related conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ
2024-12-04 - 2025-03-04
DateOpenHighLowCloseVolumeAdjusted Close
3/03/20251.861.881.791.802,206,7161.80
2/28/20251.821.871.811.851,860,3461.85
2/27/20251.801.901.801.831,913,8231.83
2/26/20251.831.861.781.803,570,1491.80
2/25/20251.781.841.761.822,479,3621.82
2/24/20251.801.821.741.772,514,4361.77
2/21/20251.941.941.781.803,987,9941.80
2/20/20251.971.981.881.912,546,1651.91
2/19/20252.072.081.971.981,654,7631.98
2/18/20252.122.142.072.071,301,0482.07
2/14/20252.132.172.112.131,310,1072.13
2/13/20252.112.142.072.141,536,3532.14
2/12/20252.082.122.082.111,272,7682.11
2/11/20252.092.122.082.101,422,7932.10
2/10/20252.142.152.092.101,686,1102.10
2/07/20252.172.192.122.141,437,1302.14
2/06/20252.192.212.162.161,094,1602.16
2/05/20252.152.172.122.171,095,5232.17
2/04/20252.132.182.132.141,343,4412.14
2/03/20252.162.192.072.124,233,5222.12
1/31/20252.302.352.222.241,852,7792.24
1/30/20252.302.352.292.301,096,7732.30
1/29/20252.292.332.232.301,718,7742.30
1/28/20252.302.352.242.291,820,1132.29
1/27/20252.352.412.282.302,176,8782.30
1/24/20252.402.402.362.381,616,0322.38
1/23/20252.382.412.272.392,566,5752.39
1/22/20252.392.402.312.393,547,2042.39
1/21/20252.112.372.072.375,642,9232.37
1/17/20251.952.091.922.076,520,0382.07
1/16/20251.951.951.901.931,398,9801.93
1/15/20251.932.001.901.941,973,4931.94
1/14/20251.901.921.861.892,193,7441.89
1/13/20251.741.981.721.873,968,6241.87
1/10/20251.781.781.731.752,276,6681.75
1/08/20251.841.861.781.791,531,7481.79
1/07/20251.871.911.841.862,016,3101.86
1/06/20251.921.931.861.871,822,5031.87
1/03/20251.901.941.871.921,937,1061.92
1/02/20251.901.941.871.901,846,6691.90
12/31/20241.850.001.901.9001.90
12/30/20241.901.941.851.852,389,4391.85
12/27/20241.921.981.911.951,633,5321.95
12/26/20241.861.931.851.931,662,3111.93
12/24/20241.861.871.831.86513,3031.86
12/23/20241.851.871.811.851,569,3431.85
12/20/20241.771.871.751.835,921,7701.83
12/19/20241.771.821.751.811,352,3221.81
12/18/20241.881.901.741.762,683,8051.76
12/17/20241.861.891.811.871,520,4691.87
12/16/20241.841.901.811.841,816,3081.84
12/13/20241.831.861.791.851,761,0651.85
12/12/20241.901.921.821.822,429,0791.82
12/11/20241.951.961.861.923,123,4211.92
12/10/20242.032.051.971.981,959,3391.98
12/09/20242.052.082.032.041,742,5702.04
12/06/20242.022.092.002.051,548,0262.05
12/05/20242.032.041.992.021,245,4152.02